THROMBOLYTIC THERAPY

被引：92

作者：

COLLEN, D

STUMP, DC

GOLD, HK

机构：

[1] UNIV VERMONT,SCH MED,DEPT BIOCHEM,BURLINGTON,VT 05405

[2] UNIV VERMONT,SCH MED,DEPT MED,BURLINGTON,VT 05405

[3] MASSACHUSETTS GEN HOSP,DIV CARDIOL,BOSTON,MA 02114

[4] HARVARD UNIV,SCH MED,BOSTON,MA 02115

来源：

ANNUAL REVIEW OF MEDICINE | 1988年 / 39卷

关键词：

D O I：

10.1146/annurev.me.39.020188.002201

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：405 / 423

页数：19

共 87 条

[1] ANDERSON JL, 1986, CIRCULATION, V74, P6
[2] [Anonymous], 1986, Lancet, V1, P397
[3] [Anonymous], 1974, JAMA-J AM MED ASSOC, V229, P1606
[4] BACHMANN F, 1987, THROMB DIATH HAEMO, P227
[5] ANTIBODY-DIRECTED UROKINASE - A SPECIFIC FIBRINOLYTIC AGENT
BODE, C
MATSUEDA, GR
HUI, KY
HABER, E
[J]. SCIENCE, 1985, 229 (4715) : 765 - 767
[6] BODE C, 1987, J AM COLL CARDIOL, V9, pA81
[7] BONNIER JJR, 1987, DRUGS S3, V33, P30
[8] THROMBOLYTIC TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A PATIENT WITH MASSIVE PULMONARY-EMBOLISM
BOUNAMEAUX, H
VERMYLEN, J
COLLEN, D
[J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) : 64 - 65
[9] ANNOUNCEMENT OF PROTOCOL CHANGE IN THROMBOLYSIS IN MYOCARDIAL-INFARCTION TRIAL
BRAUNWALD, E
KNATTERUD, GL
PASSAMANI, ER
ROBERTSON, TL
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : 467 - 467
[10] BROCHIER ML, 1987, DRUGS S3, V33, P28